Literature DB >> 16543510

Diabetic cardiomyopathy: the search for a unifying hypothesis.

Indu G Poornima1, Pratik Parikh, Richard P Shannon.   

Abstract

Although diabetes is recognized as a potent and prevalent risk factor for ischemic heart disease, less is known as to whether diabetes causes an altered cardiac phenotype independent of coronary atherosclerosis. Left ventricular systolic and diastolic dysfunction, left ventricular hypertrophy, and alterations in the coronary microcirculation have all been observed, although not consistently, in diabetic cardiomyopathy and are not fully explained by the cellular effects of hyperglycemia alone. The recent recognition that diabetes involves more than abnormal glucose homeostasis provides important new opportunities to examine and understand the impact of complex metabolic disturbances on cardiac structure and function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16543510     DOI: 10.1161/01.RES.0000207406.94146.c2

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  211 in total

1.  Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets.

Authors:  Pavan K Battiprolu; Thomas G Gillette; Zhao V Wang; Sergio Lavandero; Joseph A Hill
Journal:  Drug Discov Today Dis Mech       Date:  2010

Review 2.  Phosphatidylinositol-3,4,5-triphosphate and cellular signaling: implications for obesity and diabetes.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Cell Physiol Biochem       Date:  2015-02-11

3.  Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat.

Authors:  Xinli Zhou; Lixin Ma; Javad Habibi; Adam Whaley-Connell; Melvin R Hayden; Roger D Tilmon; Ashley N Brown; Jeong-A Kim; Vincent G Demarco; James R Sowers
Journal:  Hypertension       Date:  2010-02-22       Impact factor: 10.190

Review 4.  Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system.

Authors:  Norbert Fülöp; Richard B Marchase; John C Chatham
Journal:  Cardiovasc Res       Date:  2006-07-29       Impact factor: 10.787

5.  Prevention of diabetes-induced myocardial dysfunction in rats using the juice of the Emblica officinalis fruit.

Authors:  Snehal S Patel; Ramesh K Goyal
Journal:  Exp Clin Cardiol       Date:  2011

Review 6.  Is diabetic cardiomyopathy a specific entity?

Authors:  Mitja Letonja; Danijel Petrovič
Journal:  World J Cardiol       Date:  2014-01-26

7.  The kinematic filling efficiency index of the left ventricle: contrasting normal vs. diabetic physiology.

Authors:  Wei Zhang; Charles S Chung; Matt M Riordan; Yue Wu; Leonid Shmuylovich; Sándor J Kovács
Journal:  Ultrasound Med Biol       Date:  2007-05-03       Impact factor: 2.998

8.  Prognostic significance of stress myocardial ECG-gated perfusion imaging in asymptomatic patients with diabetic chronic kidney disease on initiation of haemodialysis.

Authors:  Mitsuru Momose; Tetsuya Babazono; Chisato Kondo; Hideki Kobayashi; Takatomo Nakajima; Kiyoko Kusakabe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-19       Impact factor: 9.236

Review 9.  Adipose tissue biology and cardiomyopathy: translational implications.

Authors:  Aslan T Turer; Joseph A Hill; Joel K Elmquist; Philipp E Scherer
Journal:  Circ Res       Date:  2012-12-07       Impact factor: 17.367

Review 10.  Role of microangiopathy in diabetic cardiomyopathy.

Authors:  Adriana Adameova; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.